Efficacy and Safety of Branched Chain Amino Acids on Retinitis Pigmentosa: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Branched Chain Amino Acids on Retinitis Pigmentosa: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Published:2024-08-16 Issue:8 Volume:13 Page:29
ISSN:2164-2591
Container-title:Translational Vision Science & Technology
language:en
Short-container-title:Trans. Vis. Sci. Tech.

Author:

Ikeda Hanako O.¹,Hasegawa Tomoko¹²,Abe Hiroyasu³,Amino Yoko³,Nakagawa Takayuki⁴,Tada Harue³,Miyata Manabu¹,Oishi Akio¹⁵,Morita Satoshi³,Tsujikawa Akitaka¹

Affiliation:

1. Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo, Kyoto, Japan

2. Research Fellow of the Japan Society for the Promotion of Science, Tokyo, Japan

3. Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Sakyo, Kyoto, Japan

4. Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo, Kyoto, Japan

5. Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Reference39 articles.

1. Retinitis pigmentosa;Hartong;Lancet,2006

2. Current and future treatment of retinitis pigmentosa;Cross;Clin Ophthalmol,2022

3. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial;Russell;Lancet,2017

4. Efficacy, safety, and durability of Voretigene Neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials;Maguire;Ophthalmology,2019

5. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial;Ghazi;Hum Genet,2016